Christina J. Ramirez

Christina J. Ramirez

Auto-generated profile, based on publicly available information

Christina J. Ramirez

Molecular Histopathology Laboratory, Laboratory of Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 October 2024 in Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
SPSushant Patkar
Sushant Patkar
JMJoshua Mannheimer
Joshua Mannheimer
SHStephanie Harmon
Stephanie Harmon
CRChristina J. Ramirez
Christina J. Ramirez
CMChristina N. Mazcko
Christina N. Mazcko
JBJessica A. Beck
Jessica A. Beck
Purpose: Osteosarcoma is an aggressive bone cancer lacking robust biomarkers for personalized treatment. Despite its scarcity in humans, it is relatively common in adult pet dogs. This study aimed to analyze clinically annotated bulk tumor transcriptomic datasets of canine and patients with human osteosarcoma to identify potentially conserved patterns of disease progression. Experimental Design: Bulk transcriptomic data from 245 pet dogs with treatment-naïve appendicular osteosarcoma were analyzed using deconvolution to characterize the tumor microenvironment (TME). The TME of both primary and metastatic tumors derived from the same dog was compared, and its impact on canine survival was assessed. A machine learning model was developed to classify the TME based on its inferred composition using canine tumor data. This model was applied to eight independent human osteosarcoma datasets to assess its generalizability and prognostic value. Results: This study found three distinct TME subtypes of canine osteosarcoma based on cell type composition of bulk tumor samples: immune enriched, immune enriched dense extracellular matrix-like, and immune desert. These three TME-based subtypes of canine osteosarcomas were conserved in humans and could predict progression-free survival outcomes of human patients, independent of conventional prognostic factors such as percent tumor necrosis post standard of care chemotherapy treatment and disease stage at diagnosis. Conclusions: These findings demonstrate the potential of leveraging data from naturally occurring cancers in canines to model the complexity of the human osteosarcoma TME, offering a promising avenue for the discovery of novel biomarkers and developing more effective precision oncology treatments.

16 December 2024
Verified
Other
Open access
SPSushant Patkar
Sushant Patkar
JMJoshua Mannheimer
Joshua Mannheimer
SHStephanie Harmon
Stephanie Harmon
CRChristina J. Ramirez
Christina J. Ramirez
CMChristina N. Mazcko
Christina N. Mazcko
JBJessica A. Beck
Jessica A. Beck
Document containing Supplementary Table legends and supplementary Figures S1-S11

16 December 2024
Verified
Other
Open access
SPSushant Patkar
Sushant Patkar
JMJoshua Mannheimer
Joshua Mannheimer
SHStephanie Harmon
Stephanie Harmon
CRChristina J. Ramirez
Christina J. Ramirez
CMChristina N. Mazcko
Christina N. Mazcko
JBJessica A. Beck
Jessica A. Beck
Gene set enrichment analysis results of cancer Hallmark pathways enriched in the ID (Immune Desert) TME subtype

16 December 2024
Verified
Other
Open access
SPSushant Patkar
Sushant Patkar
JMJoshua Mannheimer
Joshua Mannheimer
SHStephanie Harmon
Stephanie Harmon
CRChristina J. Ramirez
Christina J. Ramirez
CMChristina N. Mazcko
Christina N. Mazcko
JBJessica A. Beck
Jessica A. Beck
Gene set enrichment analysis results of cancer Hallmark pathways enriched in the IE (Immune Enriched) TME subtype

16 December 2024
Verified
Other
Open access
SPSushant Patkar
Sushant Patkar
JMJoshua Mannheimer
Joshua Mannheimer
SHStephanie Harmon
Stephanie Harmon
CRChristina J. Ramirez
Christina J. Ramirez
CMChristina N. Mazcko
Christina N. Mazcko
JBJessica A. Beck
Jessica A. Beck
Gene set enrichment analysis results of cancer Hallmark pathways enriched in the IE-ECM(Immune Enriched Dense Extra Cellular Matrix-like ) TME subtype

16 December 2024
Verified
Other
Open access
SPSushant Patkar
Sushant Patkar
JMJoshua Mannheimer
Joshua Mannheimer
SHStephanie Harmon
Stephanie Harmon
CRChristina J. Ramirez
Christina J. Ramirez
CMChristina N. Mazcko
Christina N. Mazcko
JBJessica A. Beck
Jessica A. Beck
QuPath (v0.5.0) Collagen quantification (%Positive Masson’s Trichrome area) outputs for each case that passed quality review.